This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent. Top assignees: Celgene Corporation, Direct Therapeutics, Inc., Other. Active years: 1991-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Lakeside Dr., Yorktown Heights, NY (US) (1991)
- Yorktown Heights, NY (US) (1992)
- Katonah, NY (US) (2004)
- Clinton, NJ (US) (2011)
Company Filing History:
1 out of 561 
1 out of 2 
2 out of 834,513 Years Active: 1991-2011
Title: The Innovations of Dennis Pietronigro
Introduction
Dennis Pietronigro is a notable inventor based in Clinton, NJ, recognized for his significant contributions to medical innovations, particularly in the treatment of lymphomas. With one patented invention, Pietronigro stands out in the field of oncology, addressing critical patient needs through his research.
Latest Patents
Pietronigro holds a patent for "Methods for treating lymphomas in certain patient populations and screening patients for said therapy." This invention reveals innovative techniques for predicting how patients with lymphoma may respond to a specific therapy regimen involving 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione. His method utilizes prognostic factors, including disease burden and absolute lymphocyte count, to tailor treatments effectively, potentially enhancing patient outcomes significantly.
Career Highlights
Dennis Pietronigro is associated with Celgene Corporation, a company known for its commitment to innovative therapies in the field of oncology and other critical domains. His work emphasizes the importance of personalized medicine in treating complex diseases like lymphoma, thereby improving survival rates and quality of life for patients.
Collaborations
Throughout his career, Pietronigro has collaborated with several esteemed colleagues, including Annette Ervin-Hayes and Jerome B. Zeldis. These partnerships highlight the collaborative spirit of research and innovation that is vital in the medical field, fostering an environment where groundbreaking ideas can flourish.
Conclusion
Dennis Pietronigro's contributions through his patented methods demonstrate a clear advancement in the treatment of lymphomas and patient care. His affiliation with Celgene Corporation and collaborative efforts with notable professionals in the industry underscore the collective pursuit of innovative solutions in medicine. As research and development progress, the impact of such inventions will undoubtedly play a crucial role in shaping future treatment paradigms for lymphoma patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile